Alarmins, COVID-19 and comorbidities
AbstractThe coronavirus SARS-CoV-2, the aetiological agent of COVID-19 disease, is representing a worldwide threat for the medical community and the society at large so that it is being defined as “the twenty-first-century disease”. Often associated with a severe cytokine storm, leading to more seve...
Main Authors: | Eleonora Di Salvo, Mario Di Gioacchino, Alessandro Tonacci, Marco Casciaro, Sebastiano Gangemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2021.1921252 |
Similar Items
-
Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review
by: Massimo De Martinis, et al.
Published: (2020-03-01) -
IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases
by: Francesco Borgia, et al.
Published: (2022-12-01) -
Schizophrenia and Alarmins
by: Huan Ma, et al.
Published: (2022-05-01) -
Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity
by: Jiram Torres-Ruiz, et al.
Published: (2021-09-01) -
The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications
by: Angela Rizzi, et al.
Published: (2023-07-01)